Immunogenicity of measles-rubella vaccine administered under India's Universal Immunization Programme in the context of measles-rubella elimination goal: A longitudinal study. [PDF]
Indian J Med Res, 2023 Verma SK +5 more
europepmc +1 more source
Healthy communities: immunisation rates for children in 2011-12 [PDF]
Immunisation helps protect individuals and the community generally against potentially serious diseases such as measles, polio, tetanus and whooping cough (pertussis).
core
Buschke-Lowenstein tumor treated with intralesional measles, mumps, and rubella vaccine. [PDF]
Indian J Sex Transm Dis AIDS, 2022 Deshmukh A +3 more
europepmc +1 more source
Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017. [PDF]
Public Health Pract (Oxf), 2023 Guo A +10 more
europepmc +1 more source
Safety and Tolerance of a Novel MMR (Measles, Mumps, and Rubella) Vaccine in Indian Children: A Real-World Evidence Study. [PDF]
CureusPula JR +10 more
europepmc +1 more source
Measles-rubella vaccine-associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child. [PDF]
Ther Adv Vaccines Immunother, 2022 Otiv M, Botre A, Shah P.
europepmc +1 more source
Mumps Outbreak in Shivamogga, India (2023-2024): Age-Specific Attack Rates, Complications, and an Economic Case for Measles-Mumps-Rubella Vaccine Inclusion in the Universal Immunization Programme. [PDF]
CureusGireesh S, Sakaleshpur Kumar V, S R R.
europepmc +1 more source
Corrigendum to "Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo" [Vaccine: X 9 (2021) 100127]. [PDF]
Vaccine X, 2022 Cheng A +5 more
europepmc +1 more source
High measles and rubella vaccine coverage and seroprevalence among Zambian children participating in a measles and rubella supplementary immunization activity. [PDF]
PLOS Glob Public HealthProsperi C +26 more
europepmc +1 more source